Daniel Ghali

Daniel Ghali currently serves as the European Head of Medical Affairs at Priothera SAS since April 2023, focusing on clinical development programs and scientific communication within the EU. Prior to this role, Daniel was the CAR-T Lead in Hematology at Bristol Myers Squibb from January 2019 to April 2023, where responsibilities included the introduction of cellular immunotherapy for hematological diseases in Austria. Additionally, Daniel contributed as a member of the Standing Committee on Rare Diseases at PHARMIG from April 2018 to April 2023 and held the position of Marketing Director in Hematology/Oncology at Celgene from June 2010 to December 2018, overseeing multiple product launches. Daniel holds a Ph.D. in Molecular Biology from the University of Vienna, completed between January 1993 and 1995.